Optical Valley Investment Exchange · Medical Devices Special Session successfully held

Hubei Daily News (Reporter Liu Jie, correspondent Li Jinzhen) On the afternoon of September 23, the sixteenth "Optics Valley Investment Investment Exchange" medical and equipment special session was successfully held at the Optics Valley Entrepreneurship Coffee Headquarters Base, which aims to promote Local high -quality local Optics Valley. Medical and equipment companies have accelerated investment and financing docking.

This road show specially covers 9 biomedical and medical device projects of Optics Valley. There are oral cancer screening of in vitro diagnostic kit development, innovative nano -antibody new drug development, minimally invasive surgical innovation medical device product line research and development, Chinese coagulation in China, coagulation in China Detective and embryonic monitoring and cultivation technology, micro -current control blood detection technology, domestic ONT sequencing TOP service provider, three types of plant -based plant -based implanted medical device research and development and production platforms, orthopedic chronic diseases and postoperative rehabilitation digital therapy, etc. The project is in the rapid development of Series A and B financing.

At the event site, the various roadshow project party made a systematic introduction to its own project advantages, product characteristics, team advantages, market prospects, profit advantages, and investment highlights. It is hoped that through this round of financing, enterprises will promote the construction of platform construction, technology research and development, and Talent introduction, marketing and other strategic layout.

The high-end preparations and improved new drugs of nano-technology Wuhan Koffu new drugs are committed to becoming a benchmark enterprise for the research and development-manufacturing-sales of domestic nano-drugs. The exclusive patent of the exclusive patent of the core product of the market-Pujulol oral solution of Hydrochloride is selected into the guidelines and expert consensus of various countries around the world. The first-line medication is included in the major national special funding and the exclusive listing. drug.

Innovative nano-antibody new drug developer Wuhan Banke creatures are one of the important features of antiviral antibody drugs. It has an original C-type nanopotic research and development platform, and has a new strategy for preventing and controlling an important disease inhaling. The domestic top antibody construction team is the core technical team. The core products are the first in China and the leading internationally, filling clinical gaps.

The well -known institutional investors at the scene actively asked questions about these high -quality projects, and proposed issues to these companies about cooperative customers, equity pricing, product research and development, market prospects, and industry comparison.

This time the Optics Valley Investment Investment Exchange has attracted more than 100 well -known venture capital institutions to participate, and the online live viewing volume has reached 40,000+.

The Hubei Daily client, paying attention to the major events of Hubei and the world, not only pushing the authoritative policies for users, fresh hot information, and practical convenience information, but also launched a series of features such as reading newspapers, newspapers, learning, online interactives.

- END -